POST Online Media Lite Edition


Change of leadership at Novimmune S.A.

Staff writer |
Geneva, Switzerland - December 22, 2015, Geneva, Switzerland - Novimmune S.A., a biotech company, appointed Eduard E. Holdener as chief executive officer of the company.


Primex Pharmaceuticals appoints Dan Spacie as global commercial head
SR Technics appoints Jean-Marc Lenz as CEO
Julius Baer appointed Philipp Rickenbacher as CEO
Asceneuron appoints Eric Yuen to board
TE Connectivity elects David M. Kerko to board